Business Wire

Three Leading Animal Health Companies Join Hands to Launch World-Class Vaccine Joint Venture Targeting Foot-and-Mouth Disease in China

Del

Shaanxi Meili Omni-Honesty Animal Health Co., Ltd., China’s world-class vaccine company targeting foot-and-mouth disease in swine, was launched on March 24th with a groundbreaking ceremony held at the Airport New City in Xi’an, capital city of Shaanxi Province. Meili Omni-Honesty is a joint venture between Boehringer Ingelheim, a leading global pharmaceutical company and the world’s second-largest animal health company, Beijing KangMu Omni-Honesty Animal Health Products Co., Ltd. (KMOH), and China Agricultural Vet. Bio. Science and Technology Co., Ltd.(ZNWT). The total investment amounts to 840 million yuan (around €108 million). The venture will focus on research, development and manufacture of vaccines against foot-and-mouth disease on a site that will answer the latest BSL3+ biosafety standards. Production is expected to start in 2021. (The venture is subject to regulatory approval.)

“China plays a key role in Boehringer Ingelheim’s global business. With the establishment of Meili Omni-Honesty, we will bring world-class vaccine technology to China and join hands with our partners to foster local R&D and production so as to serve the Chinese market. It again demonstrates our commitment of being ‘in China, for China’,” shared Hubertus von Baumbach, Chairman of the Board of Managing Directors at Boehringer Ingelheim. “Over a thousand years ago, the ancient Silk Road connected Xi’an to Lyon. Today, Lyon, where Boehringer Ingelheim’s R&D hub for state-of-the-art technology in vaccines against foot-and-mouth disease is located, and Xi’an are connected again in the Meili Omni-Honesty project” According to Hubertus von Baumbach, Boehringer Ingelheim, as a global leader in animal health, hopes to help facilitate the growth of China’s animal health industry and develop its talents. The company is committed to contributing to the country’s animal health and food safety sectors.

In January 2017, with the acquisition of Merial, Boehringer Ingelheim further strengthened its position as a global leader in animal health. The three companies involved in the Meili Omni-Honesty project all bring unique expertise to help fight foot-and-mouth disease in China. Boehringer Ingelheim is the world’s leader in Veterinary Public Health, with state-of-the-art technology for vaccines against foot-and-mouth disease. ZNWT is approved by the Ministry of Agriculture to produce the full set of vaccines against foot-and-mouth disease. KMOH has extensive market channels across the country, as well as rich marketing experience.

Foot-and-mouth disease is a highly infectious disease that currently threatens and hinders the development of the Chinese livestock industry. It poses a big threat to the health of cloven-hoofed animals such as pigs, cattle and sheep. China National Foot and Mouth Disease Reference Laboratory under Lanzhou Veterinary Research Institute is the authorized agency to identify and confirm foot-and-mouth disease. Lanzhou Veterinary Research Institute is also an authorized research institute in China to develop vaccines against foot-and-mouth virus.

“ZNWT is relying on Lanzhou Veterinary Research Institute for technical support and is playing a leading role in prevention and control of animal diseases in China,” said Zhang Yunde, Chairman and General Manager of ZNWT. He concluded that the collaboration with Boehringer Ingelheim and KMOH will lead to unprecedented advance and breakthrough in disease prevention and control, vaccine technology and market growth. The new joint venture will tap into advantages and cooperation of the three companies to shape the swine vaccine market for foot-and-mouth disease in China.

“Foot-and-mouth disease in swine is an epidemic that has a significant impact on animal husbandry and food safety. It is highly contagious and has a high mortality rate. The market is in urgent need of vaccines featuring the world’s top-level technology,” said Yuan Ximin, Chairman of Shaanxi Meili Omni-Honesty Animal Health Co., Ltd. “I believe this project will drive transformation and upgrading of China’s animal vaccine industry, and it will also help improve economic benefits for Chinese farmers.” Yuan also shared that the Airport New City in Xi’an was chosen for the Meili Omni-Honesty project because of its policy and location advantages. The Shaanxi Pilot Free Trade Zone was formally approved in 2017, bringing new opportunities for the Airport New City. This is the only free trade zone approved in northwest China, and the core area to lead Xi’an growth. The Meili Omni-Honesty project will promote development of the bio-pharmaceutical industry chain at the Airport New City and attract more healthcare players to settle there.

Please click on the link for ‘Notes to Editors’ and ‘References’: https://www.boehringer-ingelheim.com/press-release/joint-venture-targeting-foot-and-mouth-disease-china

Contact information

Boehringer Ingelheim
Corporate Communications
Media Contact - Animal Health
Matthias Kagerbauer
+49 6132 – 77 2356
Fax: +49 6132 – 77 6601
press@boehringer-ingelheim.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

New SPINRAZA® (nusinersen) Data Unveiled at AAN Annual Meeting Show Continued Improvement in Motor Function for Broad Age Range and Survival Benefit for Infants23.4.2018 11:30Pressemelding

Biogen (Nasdaq: BIIB) today announced new findings detailing the benefits that SPINRAZA® (nusinersen) demonstrates for both infantile- and later-onset spinal muscular atrophy (SMA) populations, including improvement in motor function as well as increased survival for the most severely affected. These findings are based on interim results from the SHINE open-label extension study and an analysis of SPINRAZA’s effects on mobility and fatigability in later-onset participants from the CS2/CS12 studies. The research will be presented at the American Academy of Neurology (AAN) Annual Meeting on April 21-27, 2018, in Los Angeles, California. “These results reinforce SPINRAZA’s unprecedented and compelling efficacy across a broad range of SMA populations, enabling patients to improve mobility and motor function – and, for the most severely affected, increase their chances of survival,” said Alfred Sandrock, M.D., Ph.D., executive vice president and chief medical officer at Biogen. “We look for

Country Leaders Inspired by ABB’s Breakthrough E-Mobility Technologies23.4.2018 11:06Pressemelding

The two leaders, along with ABB CEO Ulrich Spiesshofer, were shown a demonstration of the company’s new high power fast charging solution: the Terra HP EV charging station with a power output of up to 350 kW recharges a car battery in just eight minutes for 200 km reach. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180423005618/en/ From left to right: German Chancellor Angela Merkel, Mexican President Enrique Peña Nieto, ABB CEO Ulrich Spiesshofer, First Lady Mrs. Angélica Rivera, Managing Director of ABB Germany Hans-Georg Krabbe, Managing Director of ABB Mexico Vicente Magana (Photo: Business Wire) “This high-power fast charger provides electric vehicles with up to seven times more range in the same charging time than with previous models,” Spiesshofer said. “Together with our comprehensive ABB AbilityTM digital offering, we easily connect chargers to back offices, payment platforms or smart grid systems and offer our cu

Panasonic Launches Off-grid Solutions Projectto Mark Its Centenary23.4.2018 10:07Pressemelding

Panasonic Corporation announced it has kicked off a project for people living in off-grid areas that combines educational activities to promote understanding of electricity and provision of the company’s related products. The Off-grid Solutions Project is part of Panasonic’s corporate social responsibility initiatives, celebrating the centennial of the company’s founding this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180423005551/en/ Power Supply Station installed in Indonesia as part of the project (West Kalimantan) (Photo: Business Wire) This new initiative aims to support the creation of a sustainable society where each individual living without access to the power grid can lead an independent life. Panasonic will donate its products such as solar generation and storage systems, provide education and technical training to cultivate human resources, and help develop local business models taking advantage of elec

CORRECTING and REPLACING FlexTrade Launches FlexNOW Execution Management System (EMS)23.4.2018 08:56Pressemelding

Quote in sixth paragraph should be attributed to Lucas Howarth, Fund Manager at Wesleyan (sted of Chris Beton, CTO/CRO at Everett Capital Advisors). The corrected release reads: FLEXTRADE LAUNCHES FLEXNOW EXECUTION MANAGEMENT SYSTEM (EMS) – One-Click Deployment System for Hedge Funds and Mini-Primes – – MiFID II Compliant Trading for Equities, Futures & Options – FlexTrade (@FlexTrade) today announced the official release of FlexNOW, an out-of-the-box, broker neutral EMS to address the needs of hedge funds and mini-primes who require a streamlined, multi-asset trading system at the click of a button. Multi-Asset, MiFID II Compliant Trading -- Designed to handle trading for equities, futures and options, FlexNOW is MiFID II compliant; provides connectivity to leading market data providers; easily integrates with any order management system (OMS) via FIX and API; and comes with its own built-in transaction cost analysis functionality. Easy Installation -- According to Rhyd Lewis, FlexNOW

FlexTrade Launches FlexNOW Execution Management System (EMS)23.4.2018 08:00Pressemelding

FlexTrade (@FlexTrade) today announced the official release of FlexNOW, an out-of-the-box, broker neutral EMS to address the needs of hedge funds and mini-primes who require a streamlined, multi-asset trading system at the click of a button. Multi-Asset, MiFID II Compliant Trading -- Designed to handle trading for equities, futures and options, FlexNOW is MiFID II compliant; provides connectivity to leading market data providers; easily integrates with any order management system (OMS) via FIX and API; and comes with its own built-in transaction cost analysis functionality. Easy Installation -- According to Rhyd Lewis, FlexNOW Product Manager at FlexTrade UK, FlexNOW’s zero-touch onboarding and installation process gets clients up and running in a matter of minutes. “By combining the one-click installation process with secure, online connectivity, we have greatly reduced the on-boarding lead time for customers,” said Lewis. Streamlined Trading Workflows -- “We developed FlexNOW based o

Limited Edition Skechers D’Lites & Toei Animation One Piece Collection to Launch in Europe23.4.2018 07:00Pressemelding

After initially launching in Asia and with an upcoming debut in the United States and Canada, SKECHERS USA, Inc. (NYSE:SKX) is extending its popular anime collaboration to Europe as well with the launch of Skechers X One Piece. The colorful collection unites Toei Animation’s popular anime series with Skechers D’Lites, one of the footwear company’s original styles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180423005239/en/ Skechers launches limited edition One Piece collection in Europe (Photo: Business Wire) “Pairing the iconic long-running anime series One Piece with one of our top heritage styles resonated with our consumers in South Korea and China who have been driving trends for the past few years,” began Michael Greenberg, president of Skechers. “And now fashion moves at light speed, so as influencers around the world had already been embracing Skechers D’Lites and the chunky sneaker trend, we started to see style